Sign in
4

Changes in Ownership

Tarsus Pharmaceuticals, Inc. Filed Acc 0001519692-23-000010

Chief Financial Officer sold 1,004 shares at an average $12.55 ($12,603)

From the SEC's structured data for this filing

Trades in this filing

Greenstein Leonard M. · Chief Financial Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2023-03-21 Sale : show line 1 in the form −326 $12.89 $4,202 32,463 D
2023-03-22 Sale : show line 2 in the form −332 $12.64 $4,196 32,131 D
2023-03-23 Sale : show line 3 in the form −346 $12.15 $4,204 31,785 D
Open-market sales · 1,004 sh · avg $12.55 · $12,603
Loading xslF345X04/wf-form4_167961628683110.xml…